Affimed N.V.

Affimed N.V.: Proprietary ROCK® platform enabling generation of multi-specific antibodies is basis for its collaboration with Genentech ($96M upfront / $5B potential) to develop NK-cell engager-based therapeutics. Pipeline includes NK cell engager AFM13 (CD30/CD16A) to enter Ph 2 registration study in CD30-positive PTCL and an investigator-sponsored study by MDACC of AFM13 combined with allogeneic NK cells in relapsed/refractory CD30-positive lymphoma. IND cleared for AFM24, the company’s innate cell engager that targets EGFR-expressing solid tumors.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe, USA
Clinical Stage
Phase l or ll
Disease Space
Hematology, Immuno-Oncology, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
Antibodies, Platform Technology
Website:
Profiles:
Address:
Im Neuenheimer Feld 582
Heidelberg, Baden-Wurttemberg 69120
Germany

Company Participants at Hamptons CEO Roundtable 2019

  • Adi Hoess, Ph.D., Chief Executive Officer

Lead Programs

AFM13

Disease Target CD30 Immune Cell Target CD16A

Indication Phase
Hodgkin lymphoma + PD-1 1
Hodgkin lymphoma 2
Hodgkin lymphoma + adoptive NK cells Pre-clinical
CD30-positive lymphoma 2

AFM24

Disease Target EGFRwt Immune Cell Target CD16A

Indication Phase
Solid tumors Pre-clinical

Top 10 Holders of Affimed N.V.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Ridgeback Capital Management LP 5.50 6,450,000 0.00 Stakes 4/14/21
Cetera Advisors LLC 0.01 10,000 0.00 13F 3/31/21
BNP Paribas Arbitrage SA 0.01 14,692 0.00 13F 3/31/21
Vantagepoint Investment Advisers LLC 0.01 14,517 0.00 Funds 6/30/21
UBS Group AG (13f Subfiler) 0.01 13,533 0.00 13F 3/31/21
HighVista Strategies LLC 0.01 13,435 0.00 13F 3/31/21
Lazard Asset Management LLC 0.01 13,089 0.00 13F 3/31/21
Credit Suisse Securities (USA) LLC (Broker) 0.01 12,826 0.00 13F 3/31/21
De Lisle Partners LLP 0.01 13,000 0.00 Funds 5/28/21
Blackstone Alternative Investment Advisors LLC 0.01 12,700 0.00 Funds 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.